» Articles » PMID: 37810849

Clinical and Molecular Analysis of Guangxi Patients with Kabuki Syndrome and Mutations

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Oct 9
PMID 37810849
Authors
Affiliations
Soon will be listed here.
Abstract

Kabuki syndrome (KS) is a multiple congenital anomaly syndrome that is characterized by postnatal growth deficiency, hypotonia, short stature, mild-to-moderate intellectual disability, skeletal abnormalities, persistence of fetal fingertip pads, and distinct facial appearance. It is mainly caused by pathogenic/likely pathogenic variants in the or genes. Here, we described the clinical features of nine sporadic KS patients with considerable phenotypic heterogeneity. In addition to intellectual disability and short stature, our patients presented with a high prevalence of motor retardation and recurrent otitis media. We recommended that KS should be strongly considered in patients with motor delay, short stature, intellectual disability, language disorder and facial deformities. Nine variants, four of which were novel, were identified by whole-exome sequencing. The variants included five nonsense variants, two frameshift variants, one missense variant, and one non-canonical splice site variant. In addition, we reviewed the mutation types of the pathogenic variants in the ClinVar database. We also indicated that effective mRNA analysis, using biological materials from patients, is helpful in classifying the pathogenicity of atypical splice site variants. Pedigree segregation analysis may also provide valuable information for pathogenicity classification of novel missense variants. These findings extended the mutation spectrum of and provided new insights into the understanding of genotype-phenotype correlations, which are helpful for accurate genetic counseling and treatment optimization.

References
1.
Micale L, Augello B, Maffeo C, Selicorni A, Zucchetti F, Fusco C . Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients. Hum Mutat. 2014; 35(7):841-50. PMC: 4234006. DOI: 10.1002/humu.22547. View

2.
Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S . Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet. 2014; 87(3):252-8. DOI: 10.1111/cge.12363. View

3.
Cocciadiferro D, Augello B, De Nittis P, Zhang J, Mandriani B, Malerba N . Dissecting KMT2D missense mutations in Kabuki syndrome patients. Hum Mol Genet. 2018; 27(21):3651-3668. PMC: 6488975. DOI: 10.1093/hmg/ddy241. View

4.
Niikawa N, Kuroki Y, Kajii T, Matsuura N, Ishikiriyama S, Tonoki H . Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet. 1988; 31(3):565-89. DOI: 10.1002/ajmg.1320310312. View

5.
Bogershausen N, Gatinois V, Riehmer V, Kayserili H, Becker J, Thoenes M . Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2. Hum Mutat. 2016; 37(9):847-64. DOI: 10.1002/humu.23026. View